You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

BENZNIDAZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Benznidazole, and what generic alternatives are available?

Benznidazole is a drug marketed by Chemo Research Sl and is included in one NDA.

The generic ingredient in BENZNIDAZOLE is benznidazole. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the benznidazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Benznidazole

A generic version of BENZNIDAZOLE was approved as benznidazole by CHEMO RESEARCH SL on August 29th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BENZNIDAZOLE?
  • What are the global sales for BENZNIDAZOLE?
  • What is Average Wholesale Price for BENZNIDAZOLE?
Summary for BENZNIDAZOLE
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 77
Clinical Trials: 22
Patent Applications: 1,654
What excipients (inactive ingredients) are in BENZNIDAZOLE?BENZNIDAZOLE excipients list
DailyMed Link:BENZNIDAZOLE at DailyMed
Drug patent expirations by year for BENZNIDAZOLE
Recent Clinical Trials for BENZNIDAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
IC-MedTech CorporationPhase 1
Juan D. MayaPhase 2
Laboratorio Elea Phoenix S.A.Phase 3

See all BENZNIDAZOLE clinical trials

US Patents and Regulatory Information for BENZNIDAZOLE

BENZNIDAZOLE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting BENZNIDAZOLE

FOR USE IN CHILDREN AGES 2 TO 12 YEARS OLD WITH CHAGAS DISEASE
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chemo Research Sl BENZNIDAZOLE benznidazole TABLET;ORAL 209570-001 Aug 29, 2017 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chemo Research Sl BENZNIDAZOLE benznidazole TABLET;ORAL 209570-002 Aug 29, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.